Catalysts for Skyrizi
23 tracked
Mar 18, 2026
approval
SKYRIZI (RISANKIZUMAB-RZAA) — FDA approval
risankizumab
→
Mar 18, 2026
approval
SKYRIZI (RISANKIZUMAB-RZAA) — FDA approval
risankizumab
→
Mar 6, 2026
approval
SKYRIZI (RISANKIZUMAB-RZAA) — FDA approval
risankizumab
→
Mar 6, 2026
approval
SKYRIZI (RISANKIZUMAB-RZAA) — FDA approval
risankizumab
→
Sep 3, 2025
approval
SKYRIZI (RISANKIZUMAB-RZAA) — FDA approval
risankizumab
→
Sep 3, 2025
approval
SKYRIZI (RISANKIZUMAB-RZAA) — FDA approval
risankizumab
→
May 7, 2025
approval
SKYRIZI (RISANKIZUMAB-RZAA) — FDA approval
risankizumab
→
May 7, 2025
approval
SKYRIZI (RISANKIZUMAB-RZAA) — FDA approval
risankizumab
→
Jun 18, 2024
approval
SKYRIZI (RISANKIZUMAB-RZAA) — FDA approval
risankizumab
→
Jun 18, 2024
approval
SKYRIZI (RISANKIZUMAB-RZAA) — FDA approval
risankizumab
→
Mar 4, 2024
approval
SKYRIZI (RISANKIZUMAB-RZAA) — FDA approval
risankizumab
→
Mar 4, 2024
approval
SKYRIZI (RISANKIZUMAB-RZAA) — FDA approval
risankizumab
→
Jan 3, 2024
approval
SKYRIZI (RISANKIZUMAB-RZAA) — FDA approval
risankizumab
→
Jan 3, 2024
approval
SKYRIZI (RISANKIZUMAB-RZAA) — FDA approval
risankizumab
→
Sep 23, 2022
approval
SKYRIZI (RISANKIZUMAB-RZAA) — FDA approval
risankizumab
→
Sep 23, 2022
approval
SKYRIZI (RISANKIZUMAB-RZAA) — FDA approval
risankizumab
→
Jun 16, 2022
approval
SKYRIZI (RISANKIZUMAB-RZAA) — FDA approval
risankizumab
→
Jun 16, 2022
approval
SKYRIZI (RISANKIZUMAB-RZAA) — FDA approval
risankizumab
→
Jan 21, 2022
approval
SKYRIZI (RISANKIZUMAB-RZAA) — FDA approval
risankizumab
→
Apr 26, 2021
approval
SKYRIZI (RISANKIZUMAB-RZAA) — FDA approval
risankizumab
→
Apr 26, 2021
approval
SKYRIZI (RISANKIZUMAB-RZAA) — FDA approval
risankizumab
→
Mar 20, 2020
approval
SKYRIZI (RISANKIZUMAB-RZAA) — FDA approval
risankizumab
→
Apr 23, 2019
approval
SKYRIZI (RISANKIZUMAB-RZAA) — FDA approval
risankizumab
→